Genetic Signatures

Cover Page 1
Our Purpose & Vision 2
Chairman’s Letter 3
CEO Report 4
FY20 Results 5
Commercialisation Update 6
5 Key Pillars 7
Asia Pacific 8
North America 9
EMEA 10
Expanding range 11
Market Opportunities 12
Common types of SARS- Cov-2 13
Market Opportunities 14
STI Reproductive Health 15
Personnel 16
John Buckels 17
Contents 18
Financial Report 2020 19
Directors’ Report 20
For the financial year ended 30 21
Directors’ Report 22
For the financial year ended 30 23
Directors’ Report 24
For the financial year ended 30 25
Directors’ Report 26
For the financial year ended 30 27
Directors’ Report 28
For the financial year ended 30 29
Directors’ Report 30
For the financial year ended 30 31
Directors’ Report 32
For the financial year ended 30 33
Directors’ Report 34
Financial Report 35
Financial Report 36
Consolidated Statement 37
Financial Report 38
Notes to the Financial Statements 39
Financial Report 40
Notes to the Financial Statements 41
Financial Report 42
Notes to the Financial Statements 43
Financial Report 44
Notes to the Financial Statements 45
Financial Report 46
Notes to the Financial Statements 47
Financial Report 48
Notes to the Financial Statements 49
Financial Report 50
Notes to the Financial Statements 51
Financial Report 52
Notes to the Financial Statements 53
Financial Report 54
Notes to the Financial Statements 55
Financial Report 56
Notes to the Financial Statements 57
Financial Report 58
Notes to the Financial Statements 59
Financial Report 60
Notes to the Financial Statements 61
Financial Report 62
Notes to the Financial Statements 63
Directors’ Declaration 64
Auditor’s Declaration 65
Independent Auditor’s Report 66
BDO 67
Independent Auditor’s Report 68
BDO 69
Analysis of Holdings 70
Shareholder Information 71
Shareholder Information 72
Driving better healthcare 74
Genetic Signatures 75
Last Page 76

RkJQdWJsaXNoZXIy MTI3ODI1